What is the share price of Ameya Laboratories Ltd (532981)?

Company share prices are keep on changing according to the market conditions. The current trading price of Ameya Laboratories Ltd (532981) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Ameya Laboratories?

The latest standalone P/E ratio of Ameya Laboratories as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Ameya Laboratories Ltd (532981)?

The latest standalone P/B ratio of Ameya Laboratories Ltd (532981) as of 01-Jan-1970 is -0.16.

What is the 52-week high and low of Ameya Laboratories Ltd (532981)?

The 52-week high of Ameya Laboratories Ltd (532981) is Rs. 0.25 and the 52-week low is Rs. 0.23.

Ameya Laboratories Ltd (532981) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Ameya Laboratories Ltd (532981)
Brand: Ameya Laboratories

Ameya Laboratories Ltd (532981)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532981 NSE: Pharmaceuticals & Drugs | Small Cap | Ameya Laboratories Share Price

Ameya Laboratories Ltd (532981)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532981 NSE: Pharmaceuticals & Drugs | Small Cap | Ameya Laboratories Share Price

Key Metrics

Valuation Multiples

Market Cap

₹6 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹-0.8

TTM Sales

₹160 Cr.

Book Value per Share

₹-1.5

P/E Ratio

0.00

Industry PE

49.2

Price to Book (P/B)

-0.16

Price to Sales (P/S)

0.04

EV/EBITDA

12.00

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

2.13%

Return on Capital Employed (ROCE)

11.60%

Return on Assets (ROA)

1.10%

Operating Profit Margin

14.8%

Net Profit Margin

1.28%

Gross Profit Margin

5.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-1.7%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-14.23%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-73.92%

Asset Quality

Promoter Holding

39.30%

Pledged shares (%) of Promoter's holding (%)

73.79%

Reserves

₹-61 Cr.

Equity

₹24.5 Cr.

Face Value

₹1

All Time Low / High

₹0.17 / 28.57

Ameya Laboratories stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	TTM
ROCE % ⓘ	0%	21.7%	37.8%	45.2%	52%	48.2%	24.5%	17.6%	15.3%	11.6%	-
Growth Parameters ⓘ
Sales ⓘ	0	26.3	62.7	90.3	108	150	161	204	273	268	160
Sales YoY Gr.	-	NA	138%	44.1%	19.4%	39.5%	6.9%	27.2%	33.4%	-1.7%	-
Adj EPS ⓘ	0	0.1	0.1	0.4	0.8	1.1	0.7	0.9	0.7	0.2	-0.8
YoY Gr.	-	NA	180%	178.6%	112.8%	31.3%	-37.6%	29.4%	-25%	-75.8%	-
BVPS (₹) ⓘ	0	0.4	0.5	0.9	2	3.1	5.8	6.4	6.5	6.7	-1.5
Adj Net Profit ⓘ	0	0.5	2.1	5.7	13.2	18	16.3	21.2	16.1	3.8	-20
Cash Flow from Ops. ⓘ	0	3.7	-0.7	-4.7	4.6	-6.6	-42.4	13	28.5	-10.1	-
Debt/CF from Ops. ⓘ	0	1.8	-15.4	-3.7	5.7	-6.1	-1	6.2	3.4	-12.9	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	20%	18.6%	-1.7%
Adj EPS ⓘ	NA	-28.1%	-38.3%	-75.8%
BVPSⓘ	NA	27.6%	5.1%	3.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	TTM
Return on Equity % ⓘ	11.8	33.6	54.6	58.8	43.2	16.5	13.8	10	2.3	-31.2
Op. Profit Mgn % ⓘ	7.5	9.3	12.1	21	22.4	20.9	17.7	16.9	14.8	6.9
Net Profit Mgn % ⓘ	2.1	3.3	6.3	12.2	12	10.2	10.4	5.9	1.4	-12.4
Debt to Equity ⓘ	1.6	1.4	1.4	0.8	0.8	0.3	0.5	0.6	0.8	-
Working Cap Days ⓘ	0	111	113	126	160	271	296	221	238	227
Cash Conv. Cycle ⓘ	0	11	24	48	89	169	182	143	169	85

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Sales	26.34	62.70	90.32	107.82	150.41	160.78	204.46	272.67	268.04
Operating Expenses ⓘ +	24.36	56.86	79.40	85.18	116.76	127.23	168.22	226.56	228.49
Manufacturing Costs	3.21	12.80	16.43	16.18	18.14	17	16.62	19.30	20.07
Material Costs	19.66	40.56	51.64	59.47	86.72	95.26	131.85	180.07	179.17
Employee Cost	0.71	1.32	1.66	2.43	2.79	3.31	5.22	9.50	11.29
Other Costs ⓘ	0.78	2.18	9.68	7.10	9.11	11.66	14.54	17.69	17.96
Operating Profit ⓘ	1.98	5.84	10.92	22.64	33.65	33.55	36.24	46.11	39.55
Operating Profit Margin (%)	7.5%	9.3%	12.1%	21.0%	22.4%	20.9%	17.7%	16.9%	14.8%
Other Income ⓘ +	0.86	0.17	0.67	1.35	3.99	1.56	2.26	0.06	0.58
Exceptional Items ⓘ	0	0	0	0	0	0	0	-4.11	-0.56
Interest ⓘ	1.52	2.72	3.23	4.78	8.34	7.48	10.59	16.56	25.54
Depreciation ⓘ	0.41	0.49	0.63	0.95	1.41	1.70	1.92	4.45	7.68
Profit Before Tax ⓘ	0.92	2.79	7.73	18.27	27.90	25.93	25.99	21.05	6.35
Tax ⓘ	0.38	0.72	2.03	5.09	9.92	9.61	4.83	7.86	2.91
Profit After Tax	0.54	2.07	5.70	13.18	17.98	16.32	21.17	13.19	3.44
PAT Margin (%)	2.1%	3.3%	6.3%	12.2%	12.0%	10.2%	10.4%	4.8%	1.3%
Adjusted EPS (₹)	0.1	0.1	0.4	0.8	1.1	0.7	0.9	0.5	0.1
Dividend Payout Ratio (%)	27.10%	9.40%	13.70%	6.10%	6.90%	5.90%	11.40%	0%	0%

Valuation of Ameya Laboratories - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Equity and Liabilities
Shareholders Fund +	4.21	7.40	12.63	31.65	51.63	145.91	161.03	161.98	165.42
Share Capital ⓘ	0.97	1.30	5.19	7.98	8.26	12.08	24.15	24.45	24.45
Reserves ⓘ	3.24	6.10	7.44	23.67	43.37	133.83	136.88	137.53	140.97
Debt +	6.67	10.24	17.51	26.51	40.69	40.65	81.17	61.52	110.37
Long Term Debt	6.67	10.24	17.51	26.51	40.69	40.65	81.17	6.92	37.68
Short Term Debt	0	0	0	0	0	0	0	54.60	72.69
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	7.72	21.06	12.74	14.60	13.36	20.63	22.18	6.43	5.99
Others Liabilities ⓘ	1.79	2.48	4.62	7.79	20.29	17.05	17.44	60.90	52.20
Total Liabilities ⓘ	20.38	41.18	47.50	80.53	125.96	224.23	281.81	290.84	333.98
Fixed Assets
Net Fixed Assets ⓘ +	7.70	7.41	13.61	20.82	22.27	26.60	40.46	93.82	93.69
Gross Block	8.83	9.03	15.86	24.01	26.87	32.88	48.67	117.26	123.01
Accumulated Depreciation	1.13	1.62	2.25	3.20	4.60	6.29	8.21	23.45	29.32
CWIP ⓘ	0	2.57	0.01	3.83	4.33	17.03	40.76	21.98	35.16
Investments ⓘ	0	0.29	1.89	2.69	2.69	2.69	2.69	0.01	0.01
Inventories	8.16	17.96	23.28	34.51	54.81	70.25	74.50	69.19	66.40
Trade Receivables	3.50	9.56	5.10	7.28	22.84	62.01	67.01	55.17	83.36
Cash Equivalents	0.05	0.42	0.15	1.78	1.26	3.57	4.53	6.80	3.56
Others Assets ⓘ	0.97	2.97	3.46	9.62	17.76	42.08	51.87	43.86	51.79
Total Assets ⓘ	20.38	41.18	47.50	80.53	125.96	224.23	281.81	290.84	333.98

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Cash Flow From Operating Activity ⓘ +	3.66	-0.67	-4.68	4.62	-6.62	-42.37	13.03	28.46	-10.13
PBT ⓘ	0.46	2.09	5.70	18.27	27.90	25.93	25.99	25.16	6.91
Adjustment ⓘ	1.93	4.51	-2.14	5.72	9.63	10.78	14.18	20.95	33.22
Changes in Working Capital ⓘ	1.26	-7.27	-8.24	-17.47	-44.04	-65.74	-16.8	-13.14	-46.51
Tax Paid ⓘ	0	0	0	-1.89	-0.10	-13.34	-8.84	-5.83	-3.19
Cash Flow From Investing Activity ⓘ +	-1.78	-3.07	-5.87	-12.76	-3.23	-18.73	-39.51	-22.60	-18.93
Capex	-1.80	-2.77	-4.27	-11.98	-3.36	-18.73	-39.51	-22.60	-18.93
Net Investments	0	-0.29	-1.60	-0.80	0	0	0	0	0
Others ⓘ	0.02	0	0	0.02	0.13	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-1.89	4.09	10.28	9.76	9.34	63.40	27.44	-3.73	25.82
Net Proceeds from Shares ⓘ	0.10	0.22	4.14	6.02	4.10	80.22	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	8.99	14.18	0	0	7.29	12.76
Interest Paid ⓘ	-1.52	0	0	-4.78	-8.34	-7.03	-10.57	-16.50	-25.54
Dividend Paid ⓘ	-0.05	0	0	-0.47	-0.61	-1.81	-2.26	-2.42	0
Others ⓘ	-0.42	3.87	6.14	0	0	-7.98	40.27	7.90	38.61
Net Cash Flow ⓘ	-0.01	0.36	-0.27	1.63	-0.52	2.31	0.96	2.13	-3.23

Financial Ratio

PARTICULARS	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12
Ratios
ROE (%)	12.95	35.83	57.23	59.73	43.24	17.08	14.4	8.43	2.13
ROCE (%)	21.67	37.84	45.15	51.95	48.19	24.53	17.59	15.33	11.6
Asset Turnover Ratio	1.48	2.29	2.27	1.88	1.62	1.01	0.86	1.02	0.9
PAT to CFO Conversion(x)	6.78	-0.32	-0.82	0.35	-0.37	-2.6	0.62	2.16	-2.94
Working Capital Days
Receivable Days	42.40	33.80	26.60	18.70	32.90	87.40	107.70	76.70	90.30
Inventory Days	98.90	67.50	74.70	87.40	97.40	128.80	120.80	90.20	88.40
Payable Days	143.20	129.50	119.50	83.90	58.80	65.10	59.30	29	12.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

52.99

37.42

45.12

65.96

66.12

69.89

69.16

74.84

73.79

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ameya Laboratories Ltd FAQs

The current trading price of Ameya Laboratories on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Ameya Laboratories stood at ₹5.87 Cr

The latest P/E ratio of Ameya Laboratories as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Ameya Laboratories as of 31-Dec-1969 is -0.16.

The 52-week high of Ameya Laboratories is ₹0.25 and the 52-week low is ₹0.23.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ameya Laboratories is ₹160 ( Cr.) .

Data is not available for this company.

No data found

About Ameya Laboratories Ltd

Anu's Laboratories is an ISO 9001:2000 certified company established in 1996, engaged in the manufacture of quality drug intermediates to meet the needs of international customers. The optimized process of 2, 4- Dichloro- 5 Fluoro Acetophenone has enabled the brand to establish itself as the flagship product of the organization. It is available to its wide customer base as a competitive product of the highest quality. Other high quality intermediates such as Chlorohexanone, 1, 3-Dibromo Propane are also available to its valued customers. The company is also producing Methyl- 4 (4-Chloro 1 oxo butyl), a Di-Methyl Acetate. Its state-of-the-art R&D facilities, located at Balanagar, Hyderabad, support the process of product development, contract research and customised synthesis programmes of the organization.

The company has entered into a job work agreement with Nitya Laboratories for manufacture of Sodium Methoxide or Sodium Methylate Solution and Powder and CIS (+) Hydroxide Lactum. Nitya Laboratories is one of the promoter group company involved in the manufacturing of fine chemicals and intermediates.

In 2010 Anu's Laboratories acquired Stilbene Chemicals Ltd.

Products

Basic Intermediates
Advanced Intermediates
Fine Chemicals
Products in pipeline

Achievements

The company received the state level Best SSI Entrepreneur Award for the year 2001-02 from the AP state government.
The company was awarded the Market Penetration Leadership in the Indian Pharmaceutical Intermediates Market by M/s Frost & Sullivan for the year 2005.
Consistent and long-term relationship with customers.
Developed â€˜A Cleaner Production Processâ€™ by recovering by-products of commercial value from waste water.
Challenged the Chinese monopoly & attained leadership position in many of its products.
Developed and commercialized new intermediates; many more in pipeline.
ISO 9001 and Q9001-2000 Certifications.
Anu's R&D recognized by Department of Scientific and Industrial Research (DSIR), Government of India, New Delhi.

Ameya Laboratories Ltd (532981)

Ameya Laboratories Ltd (532981)

Ameya Laboratories stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ameya Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ameya Laboratories Ltd FAQs

About Ameya Laboratories Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ameya Laboratories Ltd (532981)

Ameya Laboratories Ltd (532981)

Ameya Laboratories stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ameya Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ameya Laboratories Ltd FAQs

What is the share price of Ameya Laboratories?

What is the market cap of Ameya Laboratories?

What is the P/E ratio of Ameya Laboratories?

What is the P/B ratio of Ameya Laboratories?

What is the 52-week high and low of Ameya Laboratories?

What is the TTM revenue of Ameya Laboratories?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Ameya Laboratories Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.